WBA Stock Price Performance Walgreens shares have struggled in the past year, plummeting 62.9% compared with the industry’s 47.2% decline and the S&P 500’s 25.9% growth.

Overall, Walgreens stock looks undervalued at its current levels of around $18, irrespective of the Boots deal.

As a result, the stock had its best day in years. Could Walgreens finally be on the right path, and is the stock overdue for a much larger rally in the weeks and months ahead?

Pfizer has been a big name in healthcare for decades, but it has been a largely underwhelming investment over the past 10 ...

Walgreens' stock price isn't going anywhere fast Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

Walgreens Boots Alliance's financials indicate a gross profit but far too much SG&A. Find out why I think you should get involved with WBA stock.

Walgreens Is Soaring on Friday. Here's Why The Beaten-Down Healthcare Stock Bounced. Matt Frankel, The Motley Fool Fri, Jan 10, 2025, 1:08 PM2 min read ...

The company’s top directors — including CEO Tim Wentworth and CFO Manmohan Mahajan — allegedly breached their fiduciary duty by inflating Walgreens’ performance projections.

It isn't a bad business model, but the U.S. market is largely saturated. Competition is fierce, and more and more ways to buy medication now exist, exacerbating the issue. They include grocery stores, ...